Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomach Neoplasms 30 Carcinoma, Hepatocellular 22 Small Cell Lung Carcinoma 15 Colorectal Neoplasms 14 Carcinoma, Non-Small-Cell Lung 14 Sarcoma 13 Ovarian Neoplasms 12 Breast Neoplasms 12 Triple Negative Breast Neoplasms 9 Nasopharyngeal Carcinoma 9 Esophageal Squamous Cell Carcinoma 9 Cholangiocarcinoma 9 Biliary Tract Neoplasms 7 Squamous Cell Carcinoma of Head and Neck 6 Osteosarcoma 6 Lung Neoplasms 6 Pancreatic Neoplasms 5 Head and Neck Neoplasms 5 Esophageal Neoplasms 5 Uterine Cervical Neoplasms 4 Thyroid Neoplasms 4 Neoplasms 4 Melanoma 4 Solid Tumor 3 Recurrence 3 Neoplasm Metastasis 3 Liver Neoplasms 3 Glioma 3 Gastric Adenocarcinoma 3 Carcinoma, Adenoid Cystic 3

Interventions

Gemcitabine 6 130-nm albumin-bound paclitaxel 5 Albumin-Bound Paclitaxel 4 Taxes 3 S 1 (combination) 3 Drug Therapy 2 toripalimab 1 surufatinib 1 paricalcitol 1 nimotuzumab 1 irinotecan sucrosofate 1 gimeracil 1 envafolimab 1 endostar protein 1 camrelizumab 1 cabiralizumab 1 apatinib 1 Tegafur 1 Radiosurgery 1 Oxaliplatin 1 Nivolumab 1 Leucovorin 1 Irinotecan 1 Immunotherapy 1 IMM-101 1 Fluorouracil 1 Endostatins 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Advanced Pancreatic Cancer × apatinib × Clear all

NCT03662035 2018-09-19

ASPC

Changzhou No.2 People's Hospital

Phase 2 Unknown

Gastrointestinal

Advanced Pancreatic Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡